Publication
Article
Pharmacy Times
The American Diabetes Association (ADA) has advised that diabeticsconsider taking a statin to lower cholesterol, even if theyalready have low cholesterol levels. Because diabetics are in thehigh-risk category for heart disease, statins will benefit them,according to the association's latest treatment guidelines.
The new guidelines stem from the results of a British studyreported in early 2004 in The Lancet. The study of adults over age40 found that individuals who took statins had a one third lower riskof stroke. "It is now a consensus that having diabetes is the equivalentin terms of cardiovascular risk of already having had a heartattack," said Nathaniel Clark, MD, PhD, vice president for clinicalaffairs for the ADA.
In the past 5 years, studies have indicated that statins can lowerthe levels of C-reactive protein—a substance in the blood that is asign of inflammation in the body and is a predictor of heart disease.A major study called the JUPITER Trial is under way to investigatewhether statins can prevent first-time heart attack, stroke, or othercardiovascular disease in individuals who have low low-densitylipoprotein but whose levels of C-reactive protein are high. "Inflammationin general, and C-reactive protein in particular, is a risk factorfor diabetes," said Paul Ridker, MD, MPH, who is leading theJUPITER Trial.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.